Beond Ibogaine, Honestly: What the Clinic Is, What It Isn't, and Who It's For

When I was researching ibogaine, Beond was the only clinic I had heard of. They have that kind of reach. I went through their site carefully. Then I looked at their pricing and I almost gave up on the idea entirely. It seemed out of range, and if Beond was what ibogaine looked like, maybe ibogaine was not going to be in the cards for me. A friend, by chance, happened to know a clinic owner in Mexico and connected me. That introduction changed the trajectory of my treatment, and of my life. If I almost talked myself out of this medicine at a pricing page, I doubt I am alone in that. So here is what I would have wanted someone to tell me at that point in my own search: an honest, independent answer to the question you almost certainly came in with when you typed "Beond Ibogaine" into a search bar. What is this place, actually, and what should you know before you let its pricing page decide for you?

Part 1. What Beond Is

Beond is the most-Googled ibogaine treatment center in the United States. They got quoted in the CNN, CNBC, and Fortune coverage of the April 18, 2026 Trump psychedelics executive order. If you typed "Beond Ibogaine" into a search bar and landed at this article, you are not the first person this month to do that. You are probably not the first this hour.

Beond was founded in early 2022 by Tom Feegel and Talia Eisenberg. Eisenberg's path into the work is the most-told version of the founding story: she discovered ibogaine through a friend, did a session herself, and was free of physical opioid withdrawal and cravings within roughly ten hours. That experience, by her own account in interviews, is what made her decide there should be a more rigorous, medically infrastructured way to deliver this treatment than what existed at the time. Feegel's path is the less-told version, and the one he tends to share himself: he was Beond's first treatment client. "Client #1," as the company puts it. The CEO is also a patient.

The clinic operates from a campus in Cancun, Quintana Roo. The medical operation is led by Dr. Eduardo Ramirez, M.D. as Clinical Director. Cardiac monitoring during treatment includes continuous bedside cardiac monitoring with QT/QTc alarm, serial EKGs, and pulse oximetry. This is standard-of-care for any Mexican clinic doing this work safely, but Beond emphasizes it more prominently than most.

The scale is what's hard to convey from the website. By their own reporting Beond has treated more than 3,000 clients across the life of the company, with roughly 2,000 in the past year. That volume is unusual in the Mexican ibogaine market, which mostly runs smaller programs. Beond is in a different size category. That has consequences in both directions, and a fair primer needs to name both.

Part 2. What You Get, and What It Costs

A full Beond program covers medical screening (EKGs, bloodwork, cardiac evaluations, and psychological assessment), pre-treatment preparation work with a coach, the medically supervised ibogaine session itself, on-site recovery, and a structured integration arc that extends after the client returns home. Length of stay averages about ten days. Beond is explicit that pricing is not per-day; the price covers the full arc.

The four standard programs are:

• Mood, Trauma & PTSD: depression, anxiety, PTSD, and complex trauma. The flagship non-addiction track.
• Chemical & Behavioral Dependency: opioids, alcohol, stimulants, prescription medications, and behavioral compulsions.
• Personal Growth / Health Optimization: for people without a clinical diagnosis. The most controversial of the four if you take a conservative editorial view of who ibogaine should be given to.
• Transitions: designed for clients whose lives are at a pivot point but who don't fit neatly into the addiction or PTSD frame.

How Beond Prices Itself: An Airline Model

The most distinctive thing about Beond's pricing is the structure of it. Beond runs three published price tiers, and the company is unusually candid about why. From their own pricing page:

Similar to purchasing an airline ticket, each month, Beond offers a percentage of our program placements at our lowest price tier of $12,500 available on a "first come, first reserved" basis. These lowest-price program opportunities fill up quickly.

The three tiers, in their own words:

• $12,500 per program: the lowest tier, reserved for clients who book at least 90 days in advance of admission after clinical approval. Capacity is limited each month and these slots fill first.
• $15,500 per program: a middle tier, an additional monthly allocation released after the $12,500 slots are full.
• $19,500 per program: the highest tier. The company describes this as reserved for "unplanned admissions to people who need treatment immediately." It is, in airline terms, the walk-up fare.

Beond positions the tiered pricing as a queue mechanism rather than a tiered service level. What you are paying for, at the top tier, is the right to skip the 90-day wait.

The Transitions Program is a 6-night, 7-day program for clients without mood disorder or chemical dependency symptoms. Published at $15,500, with a $12,500 early-commitment tier on the same advance-booking model as the main programs.

The Beond Service program offers free or heavily subsidized treatment to a small number of veterans and first responders each year. In recent reporting Feegel has cited roughly 100 veterans treated at no cost. That program is real, it is a meaningful gesture, and it is also a small fraction of the company's annual treatment volume. Both things are true.

Part 3. The Austin Headquarters, and What It Isn't

On April 17, 2026, Beond announced a U.S. headquarters in Austin, Texas. The press release got picked up across the psychedelic-medicine press and a few mainstream outlets. It also produced a lot of confused secondhand commentary suggesting Beond was about to start treating people in the United States. That isn't what's happening.

The Austin office is for research, preparation, integration, and data infrastructure. In the company's own framing: "not the delivery of ibogaine treatment within the United States." All clinical ibogaine work still happens in Cancun. Ibogaine remains Schedule I federally in the U.S., which means a clinic legally administering it inside the country is still some distance away no matter what the Trump executive order does to FDA review timelines.

If you are looking for a clinic where you can get ibogaine treatment in the United States, Beond is not it. Nobody is, yet.

Part 4. Who Beond Is Good For, and Where Else to Look

A fair, useful answer to "should I go to Beond?" depends on what you're optimizing for.

Beond is a strong fit if you want the largest, most-resourced, most-imitated operation in the Mexican ibogaine landscape; you want the version of this treatment that has been pressure-tested across thousands of sessions; you want a clinical team with deep medical specialization rather than a small operator wearing multiple hats; you have the budget and you want the marketing-polish version of the experience.

Beond may be a less ideal fit if you want a more intimate program with a smaller staff-to-client ratio; you want direct relationship access with the founder or clinical director (something a clinic doing 2,000 cases a year cannot offer the way a clinic doing 100 cases a year can); the price point is meaningfully above what you can reach; or you want a clinic that, in 2026, hasn't already become one of the two or three names that dominate every press story written about this medicine.

One structural consideration worth naming. Beond is known in the field for high-throughput operations and comparatively shorter stays. Their shortest published program is 7 days (the Transitions track); the main programs average about ten days. Other Mexican clinics structure for longer arcs, in some cases two to four weeks. If you are optimizing strictly for time off work, that is a reason to consider Beond. If you would benefit from a longer integration on-site, it is a reason to look elsewhere.

Beond's marketing apparatus is, by some distance, the most sophisticated in the Mexican ibogaine market. That is not a knock on the clinical work, which is substantive and well-staffed. It is a comment on the press economics that follow: when one operator captures most of the available attention, the rest of the field becomes invisible by default. That dynamic is most of why a site like this exists.

There are a number of smaller Mexican clinics doing medically rigorous ibogaine work, often at lower price points, that almost never appear in the U.S. press. Some of them are profiled on this site, in plain-prose interviews rather than marketing copy. Others are still being researched. If you want to compare options before deciding, our Clinic Directory is the place to do that. We do not get paid by the clinics we cover, and we cover them whether they want us to or not.

One specific thing worth knowing if you are facing a near-term decision. Beond's $19,500 top-tier price exists because someone, every month, will need to begin treatment within weeks rather than months, and Beond reserves capacity for that. That service is real and the price reflects it. There are alternatives. The broader Mexican clinic market includes operators who can typically fit a new client in within a few weeks at lower price points across all tiers. If 90 days of lead time is not available to you and the top of Beond's range is not workable, that is not the end of the road. It is a reason to look at the Clinic Directory.

The pattern this creates is predictable. A person researching ibogaine for the first time, often under real emotional pressure, finds Beond's marketing infrastructure before they find anything else and stops looking. The rest of the field never gets a fair hearing. The cost of that is not theoretical. It is paid every week, by readers who never compared options because they didn't know there were any to compare.

That is the editorially honest version of "is Beond the right place." It is one good option, in a landscape that is wider than the Google results suggest.

A Note on Why Beond Isn't in Our Clinic Directory

A reasonable question if you've made it this far: why isn't Beond profiled in our clinic directory? Honest answer: our directory features clinics this site has independently interviewed, visited, and editorially vetted. The five profiles there are smaller operations that the U.S. press has largely overlooked, which is precisely why a site like this should be covering them. Beond does not need that from us. If we eventually have a direct, on-the-record conversation with their clinical team, that calculus may change. Until then, this primer is what we have.